{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T20:27:17Z","timestamp":1775161637412,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["5U54CA151881"],"award-info":[{"award-number":["5U54CA151881"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ijpharm.2017.08.095","type":"journal-article","created":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T01:17:49Z","timestamp":1503623869000},"page":"149-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Targeting energy metabolism of cancer cells: Combined administration of NCL-240 and 2-DG"],"prefix":"10.1016","volume":"532","author":[{"given":"Bhushan S.","family":"Pattni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditi","family":"Jhaveri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivy","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"Baleja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexei","family":"Degterev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Torchilin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2017.08.095_bib0005","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.4049\/jimmunol.1004085","article-title":"2-deoxy D-glucose prevents cell surface expression of NKG2D ligands through inhibition of N-linked glycosylation","volume":"188","author":"Andresen","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0010","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/S0021-9258(18)64100-6","article-title":"The effects of 2-deoxyglucose on the growth and metabolism of cultured human cells","volume":"236","author":"Barban","year":"1961","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0015","doi-asserted-by":"crossref","first-page":"20071","DOI":"10.1073\/pnas.1206360109","article-title":"Combination of glycolysis inhibition with chemotherapy results in an antitumor immune response","volume":"109","author":"Beneteau","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0020","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1200\/JCO.2002.20.2.379","article-title":"Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography","volume":"20","author":"Bos","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0025","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1167\/iovs.08-1751","article-title":"Targeting hypoxia, a novel treatment for advanced retinoblastoma","volume":"49","author":"Boutrid","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0030","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.neo.7900147","article-title":"Using positron emission tomography with [(18)F]FDG to predict tumor behavior in experimental colorectal cancer","volume":"3","author":"Burt","year":"2001","journal-title":"Neoplasia"},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1476-4598-1-9","article-title":"Mitochondrial defects in cancer","volume":"1","author":"Carew","year":"2002","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0040","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s11814-008-0066-6","article-title":"pH-dependent release property of dioleoylphosphatidyl ethanolamine liposomes","volume":"25","author":"Cho","year":"2008","journal-title":"Korean J. Chem. Eng."},{"issue":"Suppl. 1","key":"10.1016\/j.ijpharm.2017.08.095_bib0045","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.4103\/0973-1482.55136","article-title":"Clinical studies for improving radiotherapy with 2-deoxy-D-glucose: present status and future prospects","volume":"5","author":"Dwarakanath","year":"2009","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0050","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1021\/bi00302a029","article-title":"pH-induced destabilization of phosphatidylethanolamine-containing liposomes: role of bilayer contact","volume":"23","author":"Ellens","year":"1984","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0055","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.radonc.2009.06.025","article-title":"Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells","volume":"92","author":"Feron","year":"2009","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0060","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrc1478","article-title":"Why do cancers have high aerobic glycolysis?","volume":"4","author":"Gatenby","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0065","first-page":"444","article-title":"2-Deoxy-D-glucose enhances sensitivity of human histiocytic lymphoma U937 cells to apoptosis induced by tumor necrosis factor","volume":"55","author":"Halicka","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0070","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.canlet.2015.10.025","article-title":"Carboxyamidotriazole inhibits oxidative phosphorylation in cancer cells and exerts synergistic anti-cancer effect with glycolysis inhibition","volume":"370","author":"Ju","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0075","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1039\/C4MD00109E","article-title":"Optimization of the anti-cancer activity of phosphatidylinositol-3 kinase pathway inhibitor PITENIN-1: switching a thiourea with 1,2,3-triazole","volume":"5","author":"Kommagalla","year":"2014","journal-title":"MedChemComm"},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0080","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1158\/1535-7163.MCT-07-0310","article-title":"Under normoxia, 2-deoxy-D-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation","volume":"6","author":"Kurtoglu","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0085","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1089\/ars.2007.1714","article-title":"Differential toxic mechanisms of 2-deoxy-D-glucose versus 2-fluorodeoxy-D-glucose in hypoxic and normoxic tumor cells","volume":"9","author":"Kurtoglu","year":"2007","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0090","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0006-2952(02)01456-9","article-title":"Hypoxia increases tumor cell sensitivity to glycolytic inhibitors: a strategy for solid tumor therapy (ModelC)","volume":"64","author":"Liu","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0962-8924(99)01519-6","article-title":"PTEN: a tumour suppressor that functions as a phospholipid phosphatase","volume":"9","author":"Maehama","year":"1999","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0100","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s00280-003-0724-7","article-title":"Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-D-glucose in tumor cells treated under hypoxic vs aerobic conditions","volume":"53","author":"Maher","year":"2004","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0105","doi-asserted-by":"crossref","first-page":"e13699","DOI":"10.1371\/journal.pone.0013699","article-title":"Antiangiogenic activity of 2-deoxy-D-glucose","volume":"5","author":"Merchan","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0360-3016(96)85017-6","article-title":"Improving cancer radiotherapy with 2-deoxy-D-glucose: phase I\/II clinical trials on human cerebral gliomas","volume":"35","author":"Mohanti","year":"1996","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0115","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ijpharm.2011.05.082","article-title":"Reversal of multidrug resistance by co-delivery of tariquidar (XR9576) and paclitaxel using long-circulating liposomes","volume":"416","author":"Patel","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0120","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1007\/s11095-016-1978-1","article-title":"Targeting of micelles and liposomes loaded with the pro-apoptotic drug, NCL-240, into NCI\/ADR-RES cells in a 3D spheroid model","volume":"33","author":"Pattni","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0125","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.4161\/cc.8.23.10238","article-title":"The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma","volume":"8","author":"Pavlides","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0130","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1038\/sj.onc.1209597","article-title":"Glycolysis inhibition for anticancer treatment","volume":"25","author":"Pelicano","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0135","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jconrel.2012.09.003","article-title":"Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model","volume":"164","author":"Perche","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0140","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00280-012-2045-1","article-title":"A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors","volume":"71","author":"Raez","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0145","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0014-5793(99)00924-2","article-title":"Oxythiamine and dehydroepiandrosterone induce a G1 phase cycle arrest in Ehrlich's tumor cells through inhibition of the pentose cycle","volume":"456","author":"Rais","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0150","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s11095-016-1899-z","article-title":"Combination nanopreparations of a novel proapoptotic drug \u2013 NCL-240, TRAIL and siRNA","volume":"33","author":"Riehle","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0155","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0959-437X(98)80016-6","article-title":"Hypoxia-inducible factor 1: master regulator of O2 homeostasis","volume":"8","author":"Semenza","year":"1998","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0160","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.addr.2010.03.011","article-title":"Tumor delivery of macromolecular drugs based on the EPR effect","volume":"63","author":"Torchilin","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0165","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","article-title":"Tumor metastasis: molecular insights and evolving paradigms","volume":"147","author":"Valastyan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0170","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc839","article-title":"The phosphatidylinositol 3-kinase AKT pathway in human cancer","volume":"2","author":"Vivanco","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0175","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.124.3215.269","article-title":"On respiratory impairment in cancer cells","volume":"124","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0180","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0185","doi-asserted-by":"crossref","first-page":"D603","DOI":"10.1093\/nar\/gkn810","article-title":"HMDB: a knowledgebase for the human metabolome","volume":"37","author":"Wishart","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0190","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00280-010-1391-0","article-title":"2-Deoxy-D-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion","volume":"67","author":"Xi","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0195","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/iub.1251","article-title":"The wonders of 2-deoxy-D-glucose","volume":"66","author":"Xi","year":"2014","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0200","first-page":"3561","article-title":"Effect of 2-deoxy-D-glucose on various malignant cell lines in vitro","volume":"26","author":"Zhang","year":"2006","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ijpharm.2017.08.095_bib0205","doi-asserted-by":"crossref","first-page":"e532","DOI":"10.1038\/cddis.2013.60","article-title":"Targeting cellular metabolism to improve cancer therapeutics","volume":"4","author":"Zhao","year":"2013","journal-title":"Cell. Death. Dis."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517317308141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517317308141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T19:27:14Z","timestamp":1659382034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517317308141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0378517317308141"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.08.095","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting energy metabolism of cancer cells: Combined administration of NCL-240 and 2-DG","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.08.095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}